Laura Shawver, Director at ARS Pharmaceuticals, Inc. (SPRY), sold 17,716 shares at $6.36 ($113K) on 2023-07-07, disclosed to the SEC on 2023-07-07.
Open-market sale of $113k SPRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.36 | 8,858 | $56K | 50.0% |
| 2 | $6.36 | 8,858 | $56K | 50.0% |
| Total | $6.36 avg | 17,716 | $113K | 100% |
| Filing → |
| SPRY | SELL | 2025-02-04 | $616K | — | Filing → |
| SPRY | SELL | 2025-01-07 | $555K | — | Filing → |
| SPRY | SELL | 2024-12-04 | $5.2M | — | Filing → |